European Pharmaceutical Review

Liz Barrett, Novartis: 'My personal mission is to help find cures for cancer'
As part of EPR’s Women inspiring Pharma series, Liz Barrett, CEO Oncology, Novartis, talks to Science Editor Dr Zara Kassam about finding cures for cancer, identifying meaningful partnerships and acknowledging unconscious biases…
European Pharmaceutical Review: Our 5 Steps to GDPR Compliance
The General Data Protection Regulation (GDPR) is a new set of EU rules governing how a company manages, protects and administers personal data. Whether you are a subscriber, author, advertiser or supplier to our journal, we may hold information about you and we need to keep it private and secure.
Oral antibiotics may raise risk of kidney stones
Paediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones...
Celecoxib shows potential benefit for Duchenne muscular dystrophy
Researchers have found that the FDA-approved anti-inflammatory drug Celecoxib had beneficial effects on the muscle function in muscular dystrophy...

#soliloquy-container-60099{opacity:1}#soliloquy-container-60099 li>.soliloquy-caption{display:none}#soliloquy-container-60099 li:first-child>.soliloquy-caption{display:block} Liz Barrett, Novartis: 'My personal mission is to help find cures for cancer'

Liz Barrett, Novartis: 'My personal mission is to help find cures for cancer'

European Pharmaceutical Review: Our 5 Steps to GDPR Compliance

Oral antibiotics may raise risk of kidney stones

Celecoxib shows potential benefit for Duchenne muscular dystrophy

Latest news

JRS PHARMA

From our latest issue...

Whitepaper

Whitepaper: Applying single-use efficiencies to room-to-room fluid transfer

Supplier news...

Website development by e-Motive Media Limited.

Send this to a friend

Your emailRecipient emailYour messageWhat colour is grass?